[1] |
GANEM D,PRINCE A M.Hepatitis B virus infection-natural history and clinical consequences[J]. N Engl J Med,2004,350(11):1118-1129.
|
[2] |
World Health Organization. Hepatitis B [EB/OL]. (2016-04-01)[2017-02-01]. .
|
[3] |
LU F M,ZHUANG H.Management of hepatitis B in China[J]. Chin Med J(Engl),2009,122(1):3-4.
|
[4] |
CHEN C J,YANG H I,SU J,et al.Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level[J]. JAMA,2006,295(1):65-73.
|
[5] |
ILOEJE U H,YANG H I,SU J,et al.Predicting cirrhosis risk based on the level of circulating hepatitis B viral load[J]. Gastroenterology,2006,130(3):678-686.
|
[6] |
赖娅芳,杨岩,盛慧萍. 慢性乙型肝炎患者血清中IFN-γ、IL-10、TGF-β1水平与 HBV-DNA 载量的关系[J]. 宁夏医科大学学报,2010,32(2):211-213.
|
[7] |
牛继华,曹辉,侯彦强. 乙型肝炎病毒DNA载量与血小板参数相关性分析[J]. 国际检验医学杂志,2016,37(2):280.
|
[8] |
李双杰,覃小梅,范宸颖,等. 慢性乙型肝炎患儿HBV DNA载量与肝脏病理、肝功能、肝纤维化血清学指标的相关性分析[J]. 临床肝胆病杂志,2016,32(3):472-475.
|
[9] |
WAI C T,GREENSON J K,FONTANA R J,et al.A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C[J]. Hepatology,2003,38(2):518-526.
|
[10] |
FORNS X,AMPURDANÈS S,LLOVET J M,et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model[J]. Hepatology,2002,36(4 Pt 1):986-992.
|
[11] |
IMBERT-BISMUT F,RATZIV V,PIERONI L,et al.Biochemical markers of liver fibrosis in patients with hepatitis C virus infection:a prospective study[J]. Lancet,2001,357(9262):1069-1075.
|
[12] |
KODA M,MATUNAGA Y,KAWAKAMI M,et al.FibroIndex:a practical index for predicting significant fibrosis in patients with chronic hepatitis C[J]. Hepatology,2007,45(2):297-306.
|
[13] |
LEE C M,LEUNG T K,WANG H J,et al.Evaluation of the effect of partial splentic embolization on platelet values for liver cirrhosis patients with thrombocytopenia[J]. World J Gastroenterol,2007,13(4):619-622.
|
[14] |
LAFFI G,MARRA F,GRESELE P,et al.Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation[J]. Gastroenterology,1992,103(2):641-646.
|
[15] |
欧宏杰,潘业,刘家俊,等. 慢性乙型肝炎患者外周血小板参数与肝脏组织病理的相关性分析[J]. 肝脏,2016,21(11):915-919.
|
[16] |
都泓莲,彭颖,李烨,等. 慢性乙型肝炎患者血清肝纤维化指标与APRI指数及PLT的相关研究[J]. 检验医学与临床,2017,14(3):357-360.
|
[17] |
高改云,李海中,樊宏伟,等. 乙肝患者血小板指标及生长激素-胰岛素样生长因子轴的变化观察[J]. 中华医院感染学杂志,2016,26(23):5348-5350.
|
[18] |
FELD J J,WONG D K,HEATHCOTE E J.Endpoints of therapy in chronic hepatitis B[J]. Hepatology,2009,49(5 Suppl):S96-S102.
|
[19] |
冼永超,徐茹,杨景毅,等. 慢性乙型肝炎患者血清HBV-DNA 载量与肝组织病理的关系[J]. 中国临床医学,2007,14(3):337-338.
|
[20] |
LIN Z H,XIN Y N,DONG Q J,et al.Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis:an updated meta-analysis[J]. Hepatology,2011,53(3):726-736.
|
[21] |
GÜZELBULUT F,SEZIKLI M,AKKAN-CETINKAYA Z,et al. AST-platelet ratio index in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis B[J]. Turk J Gastroenterol,2012,23(4):353-358.
|